
Galit Alter, PhD
Vice President of Immunology Research, Moderna
Dr. Christiana (Chris) Bardon is Co-Managing Partner of MPM BioImpact and leads the firm’s public market investing as portfolio manager for BioImpact Equities and the
Sangeeta N. Bhatia is a cancer researcher, Massachusetts Institute of Technology professor and biotech entrepreneur who adapts technologies developed in the computer industry for medical
James (Jay) Bradner, MD is President of the Novartis Institutes for BioMedical Research (NIBR). Prior to joining Novartis, Dr. Bradner was on the faculty of
Gerald Chan co-founded Morningside in 1986 as a private investment group with venture capital, private equity and property investments. In the life science sector, Morningside
Susan Hockfield is Professor of Neuroscience and President Emerita at the Massachusetts Institute of Technology; she served as the sixteenth president from 2004 to 2012,
Dr. Love has served as GBT’s president and chief executive officer since 2014 and as a member of its Board of Directors since September 2013.
My deep personal interest and is in the development and commercialization of new life science and medical technology. In particular, I focus on technology innovation
Do you work at the Brigham? Still looking for a specific resource?